Emergence of resistant Candida in neutropenic patients
Braz. j. infect. dis
;
6(3): 124-128, Jun. 2002.
Article
in English
| LILACS
| ID: lil-332323
ABSTRACT
Problems with resistance to antifungal drugs have emerged due to an increase in the incidence of systemic fungal infections and widespread use of antifungal agents. Accordingly, efforts have been made to develop adequate fungal susceptibility tests. The ideal test should have high intra and inter-laboratory reproducibility, good correlation with the clinical outcome, and should be easy to perform. While no such test has yet been developed, advances have been made. Over the past decade, many reports of fungal resistance have been published, most of them in AIDS patients. Though the frequency of resistant strains is still low in neutropenic cancer patients, and is mostly limited to Candida glabrata and Candida krusei, resistance to Candida albicans has also been reported.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Candida
/
Candidiasis
/
Drug Resistance, Fungal
/
Antifungal Agents
/
Neutropenia
Type of study:
Incidence study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Braz. j. infect. dis
Journal subject:
Communicable Diseases
Year:
2002
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Federal University of Rio de Janeiro/BR
/
Universidade Federal de São Paulo/BR
Similar
MEDLINE
...
LILACS
LIS